51
|
Dalamagkas K, Tsintou M, Seifalian A, Seifalian AM. Translational Regenerative Therapies for Chronic Spinal Cord Injury. Int J Mol Sci 2018; 19:E1776. [PMID: 29914060 PMCID: PMC6032191 DOI: 10.3390/ijms19061776] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Revised: 06/05/2018] [Accepted: 06/06/2018] [Indexed: 12/22/2022] Open
Abstract
Spinal cord injury is a chronic and debilitating neurological condition that is currently being managed symptomatically with no real therapeutic strategies available. Even though there is no consensus on the best time to start interventions, the chronic phase is definitely the most stable target in order to determine whether a therapy can effectively restore neurological function. The advancements of nanoscience and stem cell technology, combined with the powerful, novel neuroimaging modalities that have arisen can now accelerate the path of promising novel therapeutic strategies from bench to bedside. Several types of stem cells have reached up to clinical trials phase II, including adult neural stem cells, human spinal cord stem cells, olfactory ensheathing cells, autologous Schwann cells, umbilical cord blood-derived mononuclear cells, adult mesenchymal cells, and autologous bone-marrow-derived stem cells. There also have been combinations of different molecular therapies; these have been either alone or combined with supportive scaffolds with nanostructures to facilitate favorable cell⁻material interactions. The results already show promise but it will take some coordinated actions in order to develop a proper step-by-step approach to solve impactful problems with neural repair.
Collapse
Affiliation(s)
- Kyriakos Dalamagkas
- The Institute for Rehabilitation and Research, Memorial Hermann Texas Medical Centre, Houston, TX 77030, USA.
- Centre for Nanotechnology & Regenerative Medicine, Division of Surgery and Interventional Science, University College of London (UCL), London NW3 2QG, UK.
| | - Magdalini Tsintou
- Centre for Nanotechnology & Regenerative Medicine, Division of Surgery and Interventional Science, University College of London (UCL), London NW3 2QG, UK.
- Center for Neural Systems Investigations, Massachusetts General Hospital/HST Athinoula A., Martinos Centre for Biomedical Imaging, Harvard Medical School, Boston, MA 02129, USA.
| | - Amelia Seifalian
- Faculty of Medical Sciences, UCL Medical School, London WC1E 6BT, UK.
| | - Alexander M Seifalian
- NanoRegMed Ltd. (Nanotechnology & Regenerative Medicine Commercialization Centre), The London BioScience Innovation Centre, London NW1 0NH, UK.
| |
Collapse
|
52
|
Bramini M, Alberini G, Colombo E, Chiacchiaretta M, DiFrancesco ML, Maya-Vetencourt JF, Maragliano L, Benfenati F, Cesca F. Interfacing Graphene-Based Materials With Neural Cells. Front Syst Neurosci 2018; 12:12. [PMID: 29695956 PMCID: PMC5904258 DOI: 10.3389/fnsys.2018.00012] [Citation(s) in RCA: 76] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Accepted: 03/26/2018] [Indexed: 12/12/2022] Open
Abstract
The scientific community has witnessed an exponential increase in the applications of graphene and graphene-based materials in a wide range of fields, from engineering to electronics to biotechnologies and biomedical applications. For what concerns neuroscience, the interest raised by these materials is two-fold. On one side, nanosheets made of graphene or graphene derivatives (graphene oxide, or its reduced form) can be used as carriers for drug delivery. Here, an important aspect is to evaluate their toxicity, which strongly depends on flake composition, chemical functionalization and dimensions. On the other side, graphene can be exploited as a substrate for tissue engineering. In this case, conductivity is probably the most relevant amongst the various properties of the different graphene materials, as it may allow to instruct and interrogate neural networks, as well as to drive neural growth and differentiation, which holds a great potential in regenerative medicine. In this review, we try to give a comprehensive view of the accomplishments and new challenges of the field, as well as which in our view are the most exciting directions to take in the immediate future. These include the need to engineer multifunctional nanoparticles (NPs) able to cross the blood-brain-barrier to reach neural cells, and to achieve on-demand delivery of specific drugs. We describe the state-of-the-art in the use of graphene materials to engineer three-dimensional scaffolds to drive neuronal growth and regeneration in vivo, and the possibility of using graphene as a component of hybrid composites/multi-layer organic electronics devices. Last but not least, we address the need of an accurate theoretical modeling of the interface between graphene and biological material, by modeling the interaction of graphene with proteins and cell membranes at the nanoscale, and describing the physical mechanism(s) of charge transfer by which the various graphene materials can influence the excitability and physiology of neural cells.
Collapse
Affiliation(s)
- Mattia Bramini
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Graphene Labs, Istituto Italiano di Tecnologia, Genova, Italy
| | - Giulio Alberini
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Department of Experimental Medicine, Università degli Studi di Genova, Genova, Italy
| | - Elisabetta Colombo
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Graphene Labs, Istituto Italiano di Tecnologia, Genova, Italy
| | - Martina Chiacchiaretta
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Department of Experimental Medicine, Università degli Studi di Genova, Genova, Italy
| | - Mattia L DiFrancesco
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Graphene Labs, Istituto Italiano di Tecnologia, Genova, Italy
| | - José F Maya-Vetencourt
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy
| | - Luca Maragliano
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy
| | - Fabio Benfenati
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Graphene Labs, Istituto Italiano di Tecnologia, Genova, Italy.,Department of Experimental Medicine, Università degli Studi di Genova, Genova, Italy
| | - Fabrizia Cesca
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.,Graphene Labs, Istituto Italiano di Tecnologia, Genova, Italy
| |
Collapse
|
53
|
Urie R, Ghosh D, Ridha I, Rege K. Inorganic Nanomaterials for Soft Tissue Repair and Regeneration. Annu Rev Biomed Eng 2018; 20:353-374. [PMID: 29621404 DOI: 10.1146/annurev-bioeng-071516-044457] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Inorganic nanomaterials have witnessed significant advances in areas of medicine including cancer therapy, imaging, and drug delivery, but their use in soft tissue repair and regeneration is in its infancy. Metallic, ceramic, and carbon allotrope nanoparticles have shown promise in facilitating tissue repair and regeneration. Inorganic nanomaterials have been employed to improve stem cell engraftment in cellular therapy, material mechanical stability in tissue repair, electrical conductivity in nerve and cardiac regeneration, adhesion strength in tissue approximation, and antibacterial capacity in wound dressings. These nanomaterials have also been used to improve or replace common surgical materials and restore functionality to damaged tissue. We provide a comprehensive overview of inorganic nanomaterials in tissue repair and regeneration, and discuss their promise and limitations for eventual translation to the clinic.
Collapse
Affiliation(s)
- Russell Urie
- Department of Chemical Engineering, Arizona State University, Tempe, Arizona 85287-6106, USA;
| | - Deepanjan Ghosh
- Department of Biological Design, Arizona State University, Tempe, Arizona 85287-6106, USA
| | - Inam Ridha
- Department of Biomedical Engineering, Arizona State University, Tempe, Arizona 85287-6106, USA
| | - Kaushal Rege
- Department of Chemical Engineering, Arizona State University, Tempe, Arizona 85287-6106, USA;
| |
Collapse
|
54
|
Rocha LA, Sousa RA, Learmonth DA, Salgado AJ. The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents. Front Pharmacol 2018; 9:164. [PMID: 29535633 PMCID: PMC5835322 DOI: 10.3389/fphar.2018.00164] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Accepted: 02/14/2018] [Indexed: 12/12/2022] Open
Abstract
Spinal cord injury (SCI) represents an extremely debilitating condition for which no efficacious treatment is available. One of the main contributors to the inhospitable environment found in SCI is the vascular disruption that happens at the moment of injury that compromises the blood-spinal cord barrier (BSCB) and triggers a cascade of events that includes infiltration of inflammatory cells, ischemia and intraparenchymal hemorrhage. Due to the unsatisfactory nature of revascularization following SCI, restoring vascular perfusion and the BSCB seems an interesting way of modulating the lesion environment into a regenerative phenotype, with a potential increase in functional recovery. Certain biomaterials possess interesting features to enhance SCI therapies, and in fact have been applied as angiogenic promoters in other pathologies. The present mini-review intends to highlight the contribution that biomaterials could make in the development of novel therapeutic solutions able to restore proper vascularization and the BSCB.
Collapse
Affiliation(s)
- Luís A. Rocha
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
- ICVS/3B’s – PT Government Associate Laboratory, Braga, Portugal
- Stemmatters, Biotecnologia e Medicina Regenerativa SA, Barco, Portugal
| | - Rui A. Sousa
- Stemmatters, Biotecnologia e Medicina Regenerativa SA, Barco, Portugal
| | | | - António J. Salgado
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
- ICVS/3B’s – PT Government Associate Laboratory, Braga, Portugal
| |
Collapse
|
55
|
Ham TR, Leipzig ND. Biomaterial strategies for limiting the impact of secondary events following spinal cord injury. Biomed Mater 2018; 13:024105. [PMID: 29155409 PMCID: PMC5824690 DOI: 10.1088/1748-605x/aa9bbb] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The nature of traumatic spinal cord injury (SCI) often involves limited recovery and long-term quality of life complications. The initial injury sets off a variety of secondary cascades, which result in an expanded lesion area. Ultimately, the native tissue fails to regenerate. As treatments are developed in the laboratory, the management of this secondary cascade is an important first step in achieving recovery of normal function. Current literature identifies four broad targets for intervention: inflammation, oxidative stress, disruption of the blood-spinal cord barrier, and formation of an inhibitory glial scar. Because of the complex and interconnected nature of these events, strategies that combine multiple therapies together show much promise. Specifically, approaches that rely on biomaterials to perform a variety of functions are generating intense research interest. In this review, we examine each target and discuss how biomaterials are currently used to address them. Overall, we show that there are an impressive amount of biomaterials and combinatorial treatments which show good promise for slowing secondary events and improving outcomes. If more emphasis is placed on growing our understanding of how materials can manage secondary events, treatments for SCI can be designed in an increasingly rational manner, ultimately improving their potential for translation to the clinic.
Collapse
Affiliation(s)
- Trevor R Ham
- Department of Biomedical Engineering, Auburn Science and Engineering Center 275, West Tower, University of Akron, Akron, OH 44325-3908, United States of America
| | | |
Collapse
|
56
|
González-Mayorga A, López-Dolado E, Gutiérrez MC, Collazos-Castro JE, Ferrer ML, del Monte F, Serrano MC. Favorable Biological Responses of Neural Cells and Tissue Interacting with Graphene Oxide Microfibers. ACS OMEGA 2017; 2:8253-8263. [PMID: 30023578 PMCID: PMC6044865 DOI: 10.1021/acsomega.7b01354] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2017] [Accepted: 11/01/2017] [Indexed: 05/24/2023]
Abstract
Neural tissue engineering approaches show increasing promise for the treatment of neural diseases including spinal cord injury, for which an efficient therapy is still missing. Encouraged by both positive findings on the interaction of carbon nanomaterials such as graphene with neural components and the necessity of more efficient guidance structures for neural repair, we herein study the potential of reduced graphene oxide (rGO) microfibers as substrates for neural growth in the injured central neural tissue. Compact, bendable, and conductive fibers are obtained. When coated with neural adhesive molecules (poly-l-lysine and N-cadherin), these microfibers behave as supportive substrates of highly interconnected cultures composed of neurons and glial cells for up to 21 days. Synaptic contacts close to rGO are identified. Interestingly, the colonization by meningeal fibroblasts is dramatically hindered by N-cadherin coating. Finally, in vivo studies reveal the feasible implantation of these rGO microfibers as a guidance platform in the injured rat spinal cord, without evident signs of subacute local toxicity. These positive findings boost further investigation at longer implantation times to prove the utility of these substrates as components of advanced therapies for enhancing repair in the damaged central neural tissue including the injured spinal cord.
Collapse
Affiliation(s)
- Ankor González-Mayorga
- Hospital
Nacional de Parapléjicos, Servicio de Salud de Castilla-La
Mancha (HNP-SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain
| | - Elisa López-Dolado
- Hospital
Nacional de Parapléjicos, Servicio de Salud de Castilla-La
Mancha (HNP-SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain
- Research
Unit of “Design and Development of Biomaterials for Neural
Regeneration”, Hospital Nacional
de Parapléjicos (HNP-SESCAM), Joint Research Unit with CSIC, 45071 Toledo, Spain
| | - María C. Gutiérrez
- Materials
Science Factory, Instituto de Ciencia de
Materiales de Madrid, Consejo Superior de Investigaciones Científicas
(ICMM-CSIC), Calle Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
| | - Jorge E. Collazos-Castro
- Hospital
Nacional de Parapléjicos, Servicio de Salud de Castilla-La
Mancha (HNP-SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain
| | - M. Luisa Ferrer
- Materials
Science Factory, Instituto de Ciencia de
Materiales de Madrid, Consejo Superior de Investigaciones Científicas
(ICMM-CSIC), Calle Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
| | - Francisco del Monte
- Materials
Science Factory, Instituto de Ciencia de
Materiales de Madrid, Consejo Superior de Investigaciones Científicas
(ICMM-CSIC), Calle Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
| | - María C. Serrano
- Research
Unit of “Design and Development of Biomaterials for Neural
Regeneration”, Hospital Nacional
de Parapléjicos (HNP-SESCAM), Joint Research Unit with CSIC, 45071 Toledo, Spain
- Materials
Science Factory, Instituto de Ciencia de
Materiales de Madrid, Consejo Superior de Investigaciones Científicas
(ICMM-CSIC), Calle Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
| |
Collapse
|
57
|
Domínguez-Bajo A, González-Mayorga A, López-Dolado E, Serrano MC. Graphene-Derived Materials Interfacing the Spinal Cord: Outstanding in Vitro and in Vivo Findings. Front Syst Neurosci 2017; 11:71. [PMID: 29085285 PMCID: PMC5649236 DOI: 10.3389/fnsys.2017.00071] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2017] [Accepted: 09/14/2017] [Indexed: 11/13/2022] Open
Abstract
The attractiveness of graphene-derived materials (GDMs) for neural applications has fueled their exploration as components of biomaterial interfaces contacting the brain and the spinal cord. In the last years, an increasing body of work has been published on the ability of these materials to create biocompatible and biofunctional substrates able to promote the growth and activity of neural cells in vitro and positively interact with neural tissues when implanted in vivo. Encouraging results in the central nervous tissue might impulse the study of GDMs towards preclinical arena. In this mini-review article, we revise the most relevant literature on the interaction of GDMs with the spinal cord. Studies involving the implantation of these materials in vivo in the injured spinal cord are first discussed, followed by models with spinal cord slides ex vivo and a final description of selected results with neural cells in vitro. A closing debate of the major conclusions of these results is presented to boost the investigation of GDMs in the field.
Collapse
Affiliation(s)
- Ana Domínguez-Bajo
- Laboratory of Interfaces for Neural Repair, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha, Toledo, Spain
| | - Ankor González-Mayorga
- Laboratory of Interfaces for Neural Repair, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha, Toledo, Spain
| | - Elisa López-Dolado
- Laboratory of Interfaces for Neural Repair, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha, Toledo, Spain.,Research Unit of "Design and development of biomaterials for neural regeneration", Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha, Joint Research Unit with CSIC, Toledo, Spain
| | - María C Serrano
- Research Unit of "Design and development of biomaterials for neural regeneration", Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha, Joint Research Unit with CSIC, Toledo, Spain.,Laboratory of Materials for Health, Instituto de Ciencia de Materiales de Madrid, Consejo Superior de Investigaciones Científicas, Madrid, Spain.,Materials Science Factory, Instituto de Ciencia de Materiales de Madrid, Consejo Superior de Investigaciones Científicas, Madrid, Spain
| |
Collapse
|
58
|
Faccendini A, Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury. Pharmaceuticals (Basel) 2017; 10:ph10030063. [PMID: 28678209 PMCID: PMC5620607 DOI: 10.3390/ph10030063] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2017] [Revised: 06/13/2017] [Accepted: 07/01/2017] [Indexed: 12/21/2022] Open
Abstract
The complex pathophysiology of spinal cord injury (SCI) may explain the current lack of an effective therapeutic approach for the regeneration of damaged neuronal cells and the recovery of motor functions. A primary mechanical injury in the spinal cord triggers a cascade of secondary events, which are involved in SCI instauration and progression. The aim of the present review is to provide an overview of the therapeutic neuro-protective and neuro-regenerative approaches, which involve the use of nanofibers as local drug delivery systems. Drugs released by nanofibers aim at preventing the cascade of secondary damage (neuro-protection), whereas nanofibrous structures are intended to re-establish neuronal connectivity through axonal sprouting (neuro-regeneration) promotion, in order to achieve a rapid functional recovery of spinal cord.
Collapse
Affiliation(s)
- Angela Faccendini
- Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy.
| | - Barbara Vigani
- Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy.
| | - Silvia Rossi
- Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy.
| | - Giuseppina Sandri
- Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy.
| | | | | | - Franca Ferrari
- Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy.
| |
Collapse
|
59
|
Cheng C, Li S, Thomas A, Kotov NA, Haag R. Functional Graphene Nanomaterials Based Architectures: Biointeractions, Fabrications, and Emerging Biological Applications. Chem Rev 2017; 117:1826-1914. [PMID: 28075573 DOI: 10.1021/acs.chemrev.6b00520] [Citation(s) in RCA: 257] [Impact Index Per Article: 36.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Functional graphene nanomaterials (FGNs) are fast emerging materials with extremely unique physical and chemical properties and physiological ability to interfere and/or interact with bioorganisms; as a result, FGNs present manifold possibilities for diverse biological applications. Beyond their use in drug/gene delivery, phototherapy, and bioimaging, recent studies have revealed that FGNs can significantly promote interfacial biointeractions, in particular, with proteins, mammalian cells/stem cells, and microbials. FGNs can adsorb and concentrate nutrition factors including proteins from physiological media. This accelerates the formation of extracellular matrix, which eventually promotes cell colonization by providing a more beneficial microenvironment for cell adhesion and growth. Furthermore, FGNs can also interact with cocultured cells by physical or chemical stimulation, which significantly mediate their cellular signaling and biological performance. In this review, we elucidate FGNs-bioorganism interactions and summarize recent advancements on designing FGN-based two-dimensional and three-dimensional architectures as multifunctional biological platforms. We have also discussed the representative biological applications regarding these FGN-based bioactive architectures. Furthermore, the future perspectives and emerging challenges will also be highlighted. Due to the lack of comprehensive reviews in this emerging field, this review may catch great interest and inspire many new opportunities across a broad range of disciplines.
Collapse
Affiliation(s)
- Chong Cheng
- Institute of Chemistry and Biochemistry, Freie Universität Berlin , Takustrasse 3, 14195 Berlin, Germany
| | - Shuang Li
- Department of Chemistry, Functional Materials, Technische Universität Berlin , Hardenbergstraße 40, 10623 Berlin, Germany
| | - Arne Thomas
- Department of Chemistry, Functional Materials, Technische Universität Berlin , Hardenbergstraße 40, 10623 Berlin, Germany
| | - Nicholas A Kotov
- Department of Chemical Engineering, University of Michigan , Ann Arbor, Michigan 48109, United States
| | - Rainer Haag
- Institute of Chemistry and Biochemistry, Freie Universität Berlin , Takustrasse 3, 14195 Berlin, Germany
| |
Collapse
|
60
|
Defteralı Ç, Verdejo R, Majeed S, Boschetti-de-Fierro A, Méndez-Gómez HR, Díaz-Guerra E, Fierro D, Buhr K, Abetz C, Martínez-Murillo R, Vuluga D, Alexandre M, Thomassin JM, Detrembleur C, Jérôme C, Abetz V, López-Manchado MÁ, Vicario-Abejón C. In Vitro Evaluation of Biocompatibility of Uncoated Thermally Reduced Graphene and Carbon Nanotube-Loaded PVDF Membranes with Adult Neural Stem Cell-Derived Neurons and Glia. Front Bioeng Biotechnol 2016; 4:94. [PMID: 27999773 PMCID: PMC5138223 DOI: 10.3389/fbioe.2016.00094] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Accepted: 11/18/2016] [Indexed: 01/03/2023] Open
Abstract
Graphene, graphene-based nanomaterials (GBNs), and carbon nanotubes (CNTs) are being investigated as potential substrates for the growth of neural cells. However, in most in vitro studies, the cells were seeded on these materials coated with various proteins implying that the observed effects on the cells could not solely be attributed to the GBN and CNT properties. Here, we studied the biocompatibility of uncoated thermally reduced graphene (TRG) and poly(vinylidene fluoride) (PVDF) membranes loaded with multi-walled CNTs (MWCNTs) using neural stem cells isolated from the adult mouse olfactory bulb (termed aOBSCs). When aOBSCs were induced to differentiate on coverslips treated with TRG or control materials (polyethyleneimine-PEI and polyornithine plus fibronectin-PLO/F) in a serum-free medium, neurons, astrocytes, and oligodendrocytes were generated in all conditions, indicating that TRG permits the multi-lineage differentiation of aOBSCs. However, the total number of cells was reduced on both PEI and TRG. In a serum-containing medium, aOBSC-derived neurons and oligodendrocytes grown on TRG were more numerous than in controls; the neurons developed synaptic boutons and oligodendrocytes were more branched. In contrast, neurons growing on PVDF membranes had reduced neurite branching, and on MWCNTs-loaded membranes oligodendrocytes were lower in numbers than in controls. Overall, these findings indicate that uncoated TRG may be biocompatible with the generation, differentiation, and maturation of aOBSC-derived neurons and glial cells, implying a potential use for TRG to study functional neuronal networks.
Collapse
Affiliation(s)
- Çağla Defteralı
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (IC-CSIC), Madrid, Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED-ISCIII), Madrid, Spain
| | - Raquel Verdejo
- Instituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), Madrid, Spain
| | - Shahid Majeed
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | - Adriana Boschetti-de-Fierro
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | - Héctor R. Méndez-Gómez
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (IC-CSIC), Madrid, Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED-ISCIII), Madrid, Spain
| | - Eva Díaz-Guerra
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (IC-CSIC), Madrid, Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED-ISCIII), Madrid, Spain
| | - Daniel Fierro
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | - Kristian Buhr
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | - Clarissa Abetz
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | | | - Daniela Vuluga
- Department of Chemistry, Center for Education and Research on Macromolecules (CERM), University of Liège, Liège, Belgium
| | - Michaël Alexandre
- Department of Chemistry, Center for Education and Research on Macromolecules (CERM), University of Liège, Liège, Belgium
| | - Jean-Michel Thomassin
- Department of Chemistry, Center for Education and Research on Macromolecules (CERM), University of Liège, Liège, Belgium
| | - Christophe Detrembleur
- Department of Chemistry, Center for Education and Research on Macromolecules (CERM), University of Liège, Liège, Belgium
| | - Christine Jérôme
- Department of Chemistry, Center for Education and Research on Macromolecules (CERM), University of Liège, Liège, Belgium
| | - Volker Abetz
- Helmholtz-Zentrum Geesthacht (HZG), Zentrum für Material- und Küstenforschung GmbH, Institut für Polymerforschung, Geesthacht, Germany
| | | | - Carlos Vicario-Abejón
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (IC-CSIC), Madrid, Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED-ISCIII), Madrid, Spain
| |
Collapse
|